BHC
Bausch Health Companies Inc

41,977
Loading...
Loading...
Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
20,700

Frequently Asked Questions

What is Market Cap of Bausch Health Companies Inc?
What is the 52-week high for Bausch Health Companies Inc?
What is the 52-week low for Bausch Health Companies Inc?
What is Bausch Health Companies Inc stock price today?
What was Bausch Health Companies Inc stock price yesterday?
What is the PE ratio of Bausch Health Companies Inc?
What is the Price-to-Book ratio of Bausch Health Companies Inc?
What is the 50-day moving average of Bausch Health Companies Inc?
How many employess does Bausch Health Companies Inc has?

Latest BHC News

View

Advertisement. Remove ads.

Advertisement. Remove ads.